Jill A Helms

age ~67

from Portola Valley, CA

Get Report

Also known as:

Jill Dr Helms
Jill Ann Helms
Jill H Rubenstein
Jull A Helms
Jill A Hlems

Phone and address:: 15 Los Charros Ln, Menlo Park, CA 94028
650 799-7570

Connected to:

Jill Helms Phones & Addresses

15 Los Charros Ln, Portola Vally, CA 94028 • 650 799-7570
Portola Valley, CA
3767 Redwood Cir, Palo Alto, CA 94306 • 650 213-8220
9 Loyola Ter, San Francisco, CA 94117 • 415 752-3929
765 Mangels Ave, San Francisco, CA 94127 • 415 585-7515
Houston, TX

Resumes

Chief Scientific Officer

view source

Location:

15 Los Charros Ln, Portola Valley, CA 94028

Industry:

Research

Work:

Ankasa Regenerative Therapeutics
Chief Scientific Officer
Follow Your Bliss Farm 2005 - 2014
Owner
Stanford University 2005 - 2014
Professor
Ucsf 1996 - 2004
Associate Professor

Education:

Stanford University
University of Minnesota
Roosevelt High School

Skills:

Cell Biology
Molecular Biology
Teaching
Cell
Stem Cells
Cell Culture
Laboratory
Research
Life Sciences
Science
Biochemistry
Medicine
Genetics
Clinical Research

Languages:

English

Jill Helms

view source

Jill Helms

view source

Jill Helms

view source

Skills:

Photoshop
Microsoft Office
Management
Microsoft Word
Microsoft Excel
English
Process Improvement
Sales
Outlook

Jill Helms

view source

Jill Helms

view source

Location:

United States

Us Patents

Use Of Liposomal Wnt Composition To Enhance Osseointegration
view source
US Patent:

20120115788, May 10, 2012
Filed:

Sep 9, 2011
Appl. No.:

13/199820
Inventors:

Jill Helms - Stanford CA, US
International Classification:

A61K 38/17
A61P 19/08
US Classification:

514 167
Abstract:

Methods and compositions are provided for the therapeutic use of Wnt proteins, for enhancing bone growth and regeneration, including repair following injury, osseointegration of implants, and the like. In some embodiments of the invention, the compositions are administered locally, e.g. by injection at the site of an injury. For certain conditions it is desirable to provide Wnt activity for short periods of time, and an effective dose will be administered over a defined, short period of time.

Wnt Compositions And Methods Of Use Thereof
view source
US Patent:

20080226707, Sep 18, 2008
Filed:

Mar 5, 2008
Appl. No.:

12/074766
Inventors:

Jill Helms - Stanford CA, US
Roeland Nusse - Stanford CA, US
Jaebeom Kim - Mountain View CA, US
Philipp Leucht - Woodside CA, US
International Classification:

A61K 9/127
A61K 38/17
A61P 19/00
US Classification:

424450, 514 12
Abstract:

Methods and compositions are provided for the therapeutic use of Wnt proteins, where the Wnt protein is inserted in the non-aqueous phase of a lipid structure. In some embodiments the Wnt protein is presented in its active conformation on an outer liposome membrane or micelle. Pharmaceutical compositions of the present invention can be administered to an animal for therapeutic purposes. In some embodiments of the invention, the compositions are administered locally, e.g. by injection at the site of an injury. For certain conditions it is desirable to provide Wnt activity for short periods of time, and an effective dose will be administered over a defined, short period of time.

Use Of Liposomal Wnt Compositions To Enhance Osseointegration
view source
US Patent:

20230050133, Feb 16, 2023
Filed:

Aug 24, 2022
Appl. No.:

17/822045
Inventors:

- Stanford CA, US
Jill Helms - Stanford CA, US
International Classification:

A61K 38/17
A61K 9/127
C07K 14/475
A61K 9/00
Abstract:

Methods and compositions are provided for the therapeutic use of Wnt proteins, for enhancing bone growth and regeneration, including repair following injury, osseointegration of implants, and the like. In some embodiments of the invention, the compositions are administered locally, e.g. by injection at the site of an injury. For certain conditions it is desirable to provide Wnt activity for short periods of time, and an effective dose will be administered over a defined, short period of time.

Wnt Compositions And Methods Of Process From Serum-Free Culturing Conditions
view source
US Patent:

20200399588, Dec 24, 2020
Filed:

Aug 18, 2020
Appl. No.:

16/996676
Inventors:

- La Jolla CA, US
Jill Helms - Portola Valley CA, US
Ying Zhu - Palo Alto CA, US
Bo Liu - Palo Alto CA, US
Stefanie Gaster - La Jolla CA, US
International Classification:

C12N 5/00
C07K 1/18
A61K 47/26
A61K 47/69
C12N 5/071
Abstract:

Disclosed herein are methods and compositions for producing a Wnt polypeptide under a serum-free condition. Also disclosed herein are methods of purifying the Wnt polypeptide from a serum-free condition.

Use Of Liposomal Wnt Compositions To Enhance Osseointegration
view source
US Patent:

20190201486, Jul 4, 2019
Filed:

Nov 8, 2018
Appl. No.:

16/184705
Inventors:

- Stanford CA, US
Jill Helms - Stanford CA, US
International Classification:

A61K 38/17
A61K 9/00
A61K 9/127
C07K 14/475
Abstract:

Methods and compositions are provided for the therapeutic use of Wnt proteins, for enhancing bone growth and regeneration, including repair following injury, osseointegration of implants, and the like. In some embodiments of the invention, the compositions are administered locally, e.g. by injection at the site of an injury. For certain conditions it is desirable to provide Wnt activity for short periods of time, and an effective dose will be administered over a defined, short period of time.

Use Of Liposomal Wnt Composition To Enhance Osseointegration
view source
US Patent:

20140371151, Dec 18, 2014
Filed:

Jul 22, 2014
Appl. No.:

14/337718
Inventors:

- PALO ALTO CA, US
Jill Helms - Stanford CA, US
International Classification:

A61K 38/17
A61K 9/00
A61K 9/127
US Classification:

514 167
Abstract:

Methods and compositions are provided for the therapeutic use of Wnt proteins, for enhancing bone growth and regeneration, including repair following injury, osseointegration of implants, and the like. In some embodiments of the invention, the compositions are administered locally, e.g. by injection at the site of an injury. For certain conditions it is desirable to provide Wnt activity for short periods of time, and an effective dose will be administered over a defined, short period of time.